Summary
CME Group Inc. filed an 8-K on May 28, 2014, detailing the results of its Annual Meeting of Shareholders held on May 21, 2014. The key outcomes from this meeting include shareholder approval for amendments to the Director Stock Plan, extending its term to May 21, 2024, and the Incentive Plan for Named Executive Officers, extending its term to May 21, 2019, and incorporating new performance metrics. Additionally, the filing reports the overwhelming approval of Ernst & Young LLP as the independent auditor for 2014 and the advisory vote on executive compensation. While most proposals passed with strong support, a significant proposal to amend the Certificate of Incorporation to reduce the number of "Class B directors" from six to three failed to receive the requisite approval from Class B shareholders. The report also lists the elected directors and nominating committee members for various share classes.
Key Highlights
- 1Shareholders approved amendments to the Director Stock Plan, extending its term by 10 years to May 21, 2024.
- 2Shareholders approved amendments to the Incentive Plan for Named Executive Officers, extending its term by 5 years to May 21, 2019, and adding performance metrics.
- 3Ernst & Young LLP was ratified as the independent auditor for 2014.
- 4An advisory vote on the compensation of named executive officers received shareholder approval.
- 5A proposal to reduce the number of "Class B directors" from six to three failed to gain sufficient approval.
- 6High shareholder turnout at the Annual Meeting, with approximately 86% of outstanding shares represented.
- 7Election of eighteen Equity Directors and various Class B Directors and Nominating Committee members.